Innovation and Protection

Innovation and Protection
Author :
Publisher : Cambridge University Press
Total Pages : 295
Release :
ISBN-10 : 9781108838634
ISBN-13 : 1108838634
Rating : 4/5 (634 Downloads)

Book Synopsis Innovation and Protection by : I. Glenn Cohen

Download or read book Innovation and Protection written by I. Glenn Cohen and published by Cambridge University Press. This book was released on 2022-04-07 with total page 295 pages. Available in PDF, EPUB and Kindle. Book excerpt: A detailed analysis of the ethical, legal, and regulatory landscape of medical devices in the US and EU.


Innovation and Protection Related Books

Innovation and Protection
Language: en
Pages: 295
Authors: I. Glenn Cohen
Categories: Law
Type: BOOK - Published: 2022-04-07 - Publisher: Cambridge University Press

GET EBOOK

A detailed analysis of the ethical, legal, and regulatory landscape of medical devices in the US and EU.
Public Health Effectiveness of the FDA 510(k) Clearance Process
Language: en
Pages: 141
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2010-10-04 - Publisher: National Academies Press

GET EBOOK

The Food and Drug Administration (FDA) is responsible for assuring that medical devices are safe and effective before they go on the market. As part of its asse
Medical Devices
Language: en
Pages: 253
Authors: Seeram Ramakrishna
Categories: Medical
Type: BOOK - Published: 2015-08-18 - Publisher: Woodhead Publishing

GET EBOOK

Medical Devices and Regulations: Standards and Practices will shed light on the importance of regulations and standards among all stakeholders, bioengineering d
Medical Device Development
Language: en
Pages: 658
Authors: Jonathan S. Kahan
Categories: Medical instruments and apparatus
Type: BOOK - Published: 2020 - Publisher:

GET EBOOK

Medical Devices and the Public's Health
Language: en
Pages: 318
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2011-11-25 - Publisher: National Academies Press

GET EBOOK

Medical devices that are deemed to have a moderate risk to patients generally cannot go on the market until they are cleared through the FDA 510(k) process. In